GloboScience
Private Company
Funding information not available
Overview
GloboScience is a specialized regulatory consulting firm that leverages deep expertise and a proprietary network to navigate complex FDA and global health authority approvals. Founded in 2019, the company differentiates itself by claiming involvement with products comprising the ten fastest FDA approvals and a track record of over 2,000 therapeutic programs. It operates as a service provider to biotech and pharma companies, helping them transform scientific data into successful regulatory strategies to achieve first-cycle approvals and accelerate time-to-market.
Technology Platform
Proprietary regulatory strategy and intelligence framework (IDEAS: Insight, Direction, Experience, Advice, Strategies) leveraging a network of former regulators and industry experts, historical data from 2000+ programs, and experience with fastest-ever FDA approvals.
Opportunities
Risk Factors
Competitive Landscape
Competes with large, full-service CROs (e.g., IQVIA, Parexel) that have regulatory divisions, as well as specialized boutique regulatory affairs consultancies. Differentiation is based on claimed elite expertise, a track record with ultra-fast approvals, and a focus on creating precedent-setting pathways rather than following standard processes.